HALIX is a biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specialising in viral vectors, recombinant proteins, and vaccines.

Located in the Leiden Bio Science Park, HALIX offers end-to-end solutions, from process development to GMP manufacturing. The company serves a range of clients, including both small startups and large pharmaceutical companies, providing tailored, flexible services to meet specific development needs. With a focus on quality, agility, and speed, HALIX ensures the successful scaling of projects through open communication and direct access to expert teams.

Key products and services:

• Viral vector manufacturing (e.g., AAV, Adenovirus, Influenza)
• Recombinant protein production (e.g., monoclonal antibodies, bispecific antibodies)
• GMP manufacturing for clinical and commercial batches
• Aseptic fill/finish and lyophilisation
• Upstream processing (small to large scale)
• Purification (depth filtration, tangential flow filtration, chromatography)

HALIX’s state-of-the-art facility, which spans 6,700 m², is fully equipped to deliver biologics manufacturing services, ensuring timely and high-quality results for a diverse array of biologic products.